Results 221 to 230 of about 94,347 (287)

MAPK Inhibitor‐Tolerant Persister Cells in Melanoma: Mechanisms and Therapeutic Vulnerabilities

open access: yesCancer Science, EarlyView.
Melanoma response to MAPK inhibition progresses from drug‐sensitive cells to drug‐tolerant persister states, which enable survival through adaptive signaling, metabolic rewiring, and phenotypic plasticity. These persister cells serve as an intermediate reservoir from which resistant tumors ultimately emerge. ABSTRACT Though major advancements have been
Bhoomi Shah   +3 more
wiley   +1 more source

Diverging in Vivo Immune Response Patterns After Oral Food Challenge in Peanut Allergic Adults

open access: yesClinical &Experimental Allergy, EarlyView.
After the oral food challenge, peanut (PN)‐allergic adults were monitored over 4 weeks, which revealed diverging immune response patterns, with strong responders (SR) exhibiting heightened Ara h 2+ B cell expansion, PN sIgE induction and increasing PN‐specific Tconv. Weak responders (WR) had more activated PN‐specific Tregs.
Florent Fauchère   +7 more
wiley   +1 more source

Antimicrobial prescribing guidelines for feedlot cattle

open access: yes
Australian Veterinary Journal, EarlyView.
P Cusack   +4 more
wiley   +1 more source

Does the teicoplanin skin test predict IgE-mediated hypersensitivity? [PDF]

open access: yesAllergol Select
Baştuğ İnan NB   +3 more
europepmc   +1 more source

Perioperative hypersensitivity reactions: a retrospective study (2018-2023) in a Lebanese tertiary clinic. [PDF]

open access: yesFront Pharmacol
Antonios D   +8 more
europepmc   +1 more source

Symptoms and Knowledge of Dental Erosion Among Hong Kong Adults. [PDF]

open access: yesInt Dent J
Sun IG   +5 more
europepmc   +1 more source

ELYFANT Study Protocol: An Observational Study to Assess Awareness of and Adherence to Advice on Early Introduction of Food Allergens and Whether It Is Preventing Food Allergy

open access: yes
Clinical &Experimental Allergy, EarlyView.
Raquel Granell   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy